Our data to this point revealed that BRCA1 mutation in mammary epithelial cells could cause oncogenic activation through the S100A9-CXCL12 axis in the mammary epithelium, promote signaling through immune cells, and induce the formation of a tumor-permissive microenvironment. This evidence concerns the gene S100A9 and neoplasm.